SIMCERE PHARMA

02096

12.5102.72% ( -0.350 )

Delay Closed: Jul 30, 16:08:22

FY2025 Earnings

Financial report interval: 2024.12.31 - 2025.12.31

Preview: SIMCERE PHARMA(02096) predict that the Revenue is 8.726 B (+22.78%), Beat estimate;the EBIT is 1.756 B (+93.28%), Beat estimate;the EPS is 4.2 (+86.55%), Beat estimate.

Actual

YoY

Estimate

YoY

Vs estimate

YoY

RevenueExceed expectations

8.73B22.78%

8.62B21.35%

+0.10B1.43%

EBITExceed expectations

1.76B93.28%

1.48B62.55%

+0.28B30.73%

EPSExceed expectations

4.201186.55%

3.932574.63%

+0.268611.92%

Revenue

ActualEstimateUnit: HKD

EBIT

ActualEstimateUnit: HKD

Net income

ActualEstimateUnit: HKD

EPS

ActualEstimateUnit: HKD